These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 104621)
1. Post-transfusion alloimmunization in patients with sickle cell disease. Orlina AR; Unger PJ; Koshy M Am J Hematol; 1978; 5(2):101-6. PubMed ID: 104621 [TBL] [Abstract][Full Text] [Related]
2. Comparative study of alloimmunization against red cell antigens in sickle cell disease & thalassaemia major patients on regular red cell transfusion. Jariwala K; Mishra K; Ghosh K Indian J Med Res; 2019 Jan; 149(1):34-40. PubMed ID: 31115372 [TBL] [Abstract][Full Text] [Related]
8. Blood group alloantibodies: an assessment of some laboratory practices. Giblett ER Transfusion; 1977; 17(4):299-308. PubMed ID: 406699 [TBL] [Abstract][Full Text] [Related]
9. Does an alloimmune response to strong immunogenic red blood cell antigens enhance a response to weaker antigens? Schonewille H; Brand A Transfusion; 2008 May; 48(5):958-63. PubMed ID: 18454736 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Aygun B; Padmanabhan S; Paley C; Chandrasekaran V Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310 [TBL] [Abstract][Full Text] [Related]
11. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review. Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266 [TBL] [Abstract][Full Text] [Related]
12. Risk factors for alloimmunization in patients with sickle cell anemia. Pinto PC; Braga JA; Santos AM Rev Assoc Med Bras (1992); 2011; 57(6):668-73. PubMed ID: 22249547 [TBL] [Abstract][Full Text] [Related]
13. DNA-based typing of blood groups for the management of multiply-transfused sickle cell disease patients. Castilho L; Rios M; Bianco C; Pellegrino J; Alberto FL; Saad ST; Costa FF Transfusion; 2002 Feb; 42(2):232-8. PubMed ID: 11896340 [TBL] [Abstract][Full Text] [Related]
14. Red blood cell alloimmunization in sickle cell disease: the influence of racial and antigenic pattern differences between donors and recipients in Brazil. Moreira Júnior G; Bordin JO; Kuroda A; Kerbauy J Am J Hematol; 1996 Jul; 52(3):197-200. PubMed ID: 8756087 [TBL] [Abstract][Full Text] [Related]
15. Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Rosse WF; Gallagher D; Kinney TR; Castro O; Dosik H; Moohr J; Wang W; Levy PS Blood; 1990 Oct; 76(7):1431-7. PubMed ID: 2207318 [TBL] [Abstract][Full Text] [Related]
17. Alloimmunization in two multitransfused patient populations. Coles SM; Klein HG; Holland PV Transfusion; 1981; 21(4):462-6. PubMed ID: 7268873 [TBL] [Abstract][Full Text] [Related]
18. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582 [TBL] [Abstract][Full Text] [Related]